ScinoPharm, an active pharmaceutical ingredient (API) specialist, today announced the company has been certified as an Authorized Economic Operator (AEO) by the Taiwanese Customs office.

ScinoPharm, a leading active pharmaceutical ingredient (API) developer and manufacturer headquartered in Taiwan, today announced an investment into Tanvex Biologics, Inc., a United States company registered in the State of Delaware.